Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein
Thomas Lindner(University of Regensburg), Uwe Haberkorn(German Cancer Research Center)
Cited by 908
Related Papers
Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine.
|PubMed|1994|63
Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review
|EJNMMI Research|2021|51
Oral Delivery of the Vancomycin Derivative FU002 by a Surface‐Modified Liposomal Nanocarrier
|Advanced Healthcare Materials|2024|28
Fatty Acid Conjugation Leads to Length-Dependent Antimicrobial Activity of a Synthetic Antibacterial Peptide (Pep19-4LF)
|Antibiotics|2020|23
Improved pharmacokinetics and enhanced efficacy of the vancomycin derivative FU002 using a liposomal nanocarrier
|Nanomedicine Nanotechnology Biology and Medicine|2023|11